Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
GLP-1 meds dont teach you this
Overview: Where GLP-1 Litigation Stands Now As of 2026, GLP-1 drug litigation is in an active investigation and litigation and early case-building phase , with: growing numbers of individual claims coordinated legal review across jurisdictions increasing focus on severe gastrointestinal and organ injuries, NAION and Vision loss expanding expert and scientific analysis litigating the consolidated proceedings in state and federal court February 3, 2026 Streamlined protocol for vision loss and NAION lawsuits in the federal eye damage MDL The United States District Judge in charge of the GLP-1 MDL lawsuits, pertaining to VISION LOSS, set forth protocol intended to make the MDL more efficient
41 High-dose niacin (a form of vitamin B3) can cause flushing that could be confused with or aggravate rosacea
PLoS ONE 7:e34263
Fortunately, a meta-analysis of SGLT2i CVOTs found that diabetic ketoacidosis was rare, occurring in 0.1 to 2.2 per 1,000 person-years in those treated with a SGLT2i, albeit with a significantly greater risk compared to placebo (HR, 2.46
Mistake 1: assuming all vials are the same concentration This is the most dangerous error
